Correlation Between Molecular Partners and Nkarta
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Nkarta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Nkarta into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Nkarta Inc, you can compare the effects of market volatilities on Molecular Partners and Nkarta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Nkarta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Nkarta.
Diversification Opportunities for Molecular Partners and Nkarta
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Nkarta is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Nkarta Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nkarta Inc and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Nkarta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nkarta Inc has no effect on the direction of Molecular Partners i.e., Molecular Partners and Nkarta go up and down completely randomly.
Pair Corralation between Molecular Partners and Nkarta
Given the investment horizon of 90 days Molecular Partners is expected to generate 2.64 times less return on investment than Nkarta. But when comparing it to its historical volatility, Molecular Partners AG is 1.55 times less risky than Nkarta. It trades about 0.03 of its potential returns per unit of risk. Nkarta Inc is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 182.00 in Nkarta Inc on September 12, 2024 and sell it today you would earn a total of 73.50 from holding Nkarta Inc or generate 40.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Nkarta Inc
Performance |
| Timeline |
| Molecular Partners |
| Nkarta Inc |
Molecular Partners and Nkarta Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Nkarta
The main advantage of trading using opposite Molecular Partners and Nkarta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Nkarta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nkarta will offset losses from the drop in Nkarta's long position.| Molecular Partners vs. Equillium | Molecular Partners vs. DiaMedica Therapeutics | Molecular Partners vs. Valneva SE ADR | Molecular Partners vs. Vivani Medical |
| Nkarta vs. Monte Rosa Therapeutics | Nkarta vs. Lyell Immunopharma | Nkarta vs. Generation Bio Co | Nkarta vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |